Dialysis requires frequent access to a person’s veins in order to circulate the blood to cleanse the liquids and waste that normally would be removed by working kidneys. Due to the recent ...

CryoLife, Inc., a leading tissue processing and medical device company focused on cardiac and vascular surgery, has performed first European clinical implant of its HeRO (Hemodialysis Reliable Outflow ...

Please provide your email address to receive an email when new articles are posted on . In an observational cohort study, researchers examined Medicare beneficiaries who recently started using an AV ...

Please provide your email address to receive an email when new articles are posted on . Xeltis, a Swiss-Dutch medical device company, reported that it implanted patients with kidney failure who ...

EDISON, N.J.--(BUSINESS WIRE)--A medical study by William C Bauer shows how thousands of “lifeline” failures can be prevented, by an improved approach to needle insertion (cannulation) during dialysis ...

OAK BROOK, Ill. – Compared to other races, African American patients are more likely to experience premature arteriovenous (AV) graft failure in the treatment of advanced kidney failure, according to ...

An investigational anticoagulant that targets factor XI failed to prevent arteriovenous graft (AVG) thrombosis in chronic hemodialysis patients, according to a placebo-controlled phase IIb trial. In ...